Sort   by:  
 Page size 
Proteomicsβ-TrCP and Casein Kinase II mediated degradation of cyclin F controls timely mitotic progression
Orderly progressions of events in the cell division cycle are necessary to ensure the replication of DNA and cell division. Checkpoint systems allow the accurate execution of each cell cycle phase. The precise regulation of the levels of cyclin proteins is fundamental to coordinate cell division w...
ORGANISM(S): Homo sapiens (Human) 
2018-10-02 | PXD010737 | Pride
Mitotic progression Ck2 Cyclin f 
UnknownA genetic probe into the ancient and medieval history of Southern Europe and West Asia.
Not available
S-EPMC10019558 | biostudies-literature
TranscriptomicsTranscription profiling of Arabidopsis response to UV-B
Seven-day-old white-light-grown Arabidopsis seedlings were exposed for 15 minutes to polychromatic radiation with decreasing short-wave cut-off in the UV range, transferred back to the standard growth chamber and samples were taken 1 and 6 hours after the start of irradiation.
ORGANISM(S): Arabidopsis thaliana 
2006-03-01 | E-MEXP-550 | biostudies-arrayexpress
UnknownLoss of α1β1 soluble guanylate cyclase, the major nitric oxide receptor, leads to moyamoya and achalasia.
Not available
S-EPMC3951937 | biostudies-literature
TranscriptomicsP24_STVI_colorectal_cancer_GEX
Focal and temporal tumor heterogeneity can represent a major challenge for biology-guided therapies. This study proposes to investigative molecular discrepancies between primary colorectal cancer samples and matched metastases
ORGANISM(S): Homo sapiens 
2014-12-30 | E-MTAB-2864 | biostudies-arrayexpress
UnknownMetformin and Time to Sustained Recovery in Adults With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC12261116 | biostudies-literature
UnknownCharacterizing Long COVID Symptoms During Early Childhood.
Not available
S-EPMC12117493 | biostudies-literature
UnknownEffect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19: The RECOVERY-RS Randomized Clinical Trial.
Not available
S-EPMC8787685 | biostudies-literature
UnknownTime to Sustained Recovery Among Outpatients With COVID-19 Receiving Montelukast vs Placebo: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC11581631 | biostudies-literature
UnknownHigher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Not available
S-EPMC10656670 | biostudies-literature
Sort   by:  
 Page size